The SIGLEC15 gene helps certain immune cells send signals and supports the normal breakdown and rebuilding of bone. If it does not work as expected, immune signaling and bone turnover may change, which can affect inflammation and how bone stays strong over time. This gene plays an important role in communication between the immune system and bone shaping cells. In medicine, the SIGLEC15 gene has drawn attention in cancer research because some tumors may use this pathway to quiet immune responses.
What is a gene?
Genes are sections of DNA that give your cells instructions to make molecules or direct processes throughout the body. Some genes carry the directions for producing proteins, the parts of cells that do much of the work. Other genes mainly control when certain processes happen, where they take place, and how strongly they are carried out. Together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. To look into this topic more closely, you can find more in the LearnHub.
Overview
SIGLEC15Gene function
What if the gene works
The SIGLEC15 gene helps certain immune cells send signals and supports normal bone remodeling. Its protein is especially active in cells that break down bone, helping keep bone turnover balanced.
Risk
What if the gene does not work
Changes in the SIGLEC15 gene can range from milder to more severe variants. They may reduce SIGLEC15 signaling in bone resorbing cells and immune cells, which can weaken cell communication and osteoclast activation.
Treatment
What does that mean for your treatment
No SIGLEC15-specific treatment or drug selection approach is currently established in clinical guidelines for people with pathogenic or loss-of-function variants in the SIGLEC15 gene. The SIGLEC15 gene is being studied as a cancer immunotherapy target and as a possible biomarker in some tumors, but this has not yet changed routine treatment choices.
Gene function
What if the gene works
Your body constantly renews bone and coordinates immune cells through surface signals. The SIGLEC15 gene helps with both jobs by making a protein found mainly on certain bone-removing cells and some immune cells. Its protein reads sugar patterns on nearby cells and sends signals that support steady, everyday cell activity.
On bone-removing cells, the SIGLEC15 gene helps pass signals that support normal bone turnover. This allows old bone to be cleared in a controlled way so new bone can take its place.
Its protein sits on the cell surface and recognizes sialic acids (small sugar tags) on nearby cells. This helps certain immune and bone cells read their surroundings and respond in an organized way.
SIGLEC15 works with helper proteins inside the cell to turn outside contact into internal messages. This is part of how the SIGLEC15 gene helps bone remodeling and routine communication in some frontline immune cells.
What is a variant?
A genetic variant is a minor difference in the DNA sequence within a gene. These differences are common and help explain normal variation among people, including differences in appearance, metabolism, and how the body reacts to environmental factors. Many variants do not cause any noticeable effect and are part of natural genetic variation. In some situations, though, a variant can change how a gene works more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Changes in the SIGLEC15 gene can alter how much protein a cell makes, whether that protein folds correctly, and whether it reaches the cell surface to interact with nearby molecules. In practical terms, how variants in the SIGLEC15 gene affect protein function depends on where the DNA change sits and how strongly it disrupts the protein’s shape or stability. Milder variants may partly reduce activity, while more severe loss of function variants can leave little or no working protein.
How variants are linked to conditions
The SIGLEC15 gene does not yet have a broadly confirmed link to a specific health condition, although research is still developing. Current evidence is not strong enough to use findings about SIGLEC15 gene variants and disease risk as a stand-alone guide for diagnosis or prediction. If you carry a variant in the SIGLEC15 gene, your clinician or genetic counselor can explain what it may or may not mean for you.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are common across the general population. Most do not directly affect health and simply reflect natural human variation. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when multiple genes and environmental factors contribute. In some situations, though, a single well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the SIGLEC15 gene. Anyone with questions about their personal or family risk can talk with a doctor or genetic counselor.
Inheritance of SIGLEC15 variants
There is not yet a broadly confirmed Mendelian inheritance pattern tied to a specific human condition for the SIGLEC15 gene, so the answer to how SIGLEC15 gene variants are inherited is still developing as research grows. The SIGLEC15 gene is located on chromosome 18, which is an autosome. That means you inherit one copy of the SIGLEC15 gene from your mother and one copy from your father.
What does my SIGLEC15 result mean for my family?
There isn't yet a broadly confirmed inheritance pattern tied to a specific health condition for SIGLEC15, though this can change as research grows. If you have a specific SIGLEC15 result and want to understand what it could mean for relatives, a doctor or genetic counselor can help explain it in the context of your family history.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a change in the SIGLEC15 gene, genetic testing for SIGLEC15 variants uses a blood or saliva sample to read the gene's DNA code. The lab checks for differences from the usual sequence and reports whether a variant was found, along with what that result may mean clinically.
When should I consider getting a genetic test?
There is not yet a broadly established SIGLEC15-specific reason for genetic testing in routine care. Testing decisions are usually based on your symptoms and family history, with a doctor or genetic counselor helping decide whether a broader genetic test would be useful.
A genetic result is only one part of your health story
Genetic test results can be informative, but what they can tell you varies with the condition and the kind of variant present. Over time, the body is shaped by many factors, including lifestyle, environment, age, and medical history. With some conditions, particularly those affected by many genes, genetic information offers context rather than certainty and makes the most sense when viewed together with other parts of care. In other situations, a genetic finding can give a definite answer. For areas like medication response, genetic results may also help put personal experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, moves it through the body, or responds at the drug’s target. This helps explain why the same treatment works well for one person, works less well for another, or causes more side effects in some people.
What is Pharmacogenetics?
Pharmacogenetics looks at how differences in a person’s genes can shape their response to medicines. It examines links between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medications, genes can affect both how strongly a drug works and how the body handles it. This information can support more informed, more individualized treatment decisions. To learn more about this topic, more information is available in the LearnHub.
Drugs influenced by the SIGLEC15 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how medicines are chosen or how well they work. If you have concerns about side effects, a treatment that is not helping, or questions about your overall health, talk with your doctor.
History
SIGLEC15 entered the scientific literature in the early 2000s, when researchers were mapping members of the siglec family, a group of genes linked by shared structural features. In recent decades, awareness of this gene’s role has grown as cancer research began paying closer attention to immune pathways that might become treatment targets. Early work focused on placing SIGLEC15 within the broader family tree of related genes and describing where it was active in the body. From these first observations, research expanded steadily, especially after studies in the late 2010s suggested that SIGLEC15 might matter in tumors that do not rely on the better known PD-1 and PD-L1 pathways. That shift moved SIGLEC15 from a relatively specialized research topic into a gene of interest in modern immunotherapy studies.